Effect of a Receptor Antagonist of Endothelin 1 (Sitaxsentan, Thelin) on Bronchial Remodeling in Severe Asthma With Fixed Bronchial Obstruction.
Phase of Trial: Phase II
Latest Information Update: 04 Jul 2012
At a glance
- Drugs Sitaxentan (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 09 May 2012 Actual patient number added 17 according to ClinicalTrials.gov.
- 09 May 2012 Actual end date (December 2010) added as reported by ClinicalTrials.gov.
- 09 May 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.